FTC and Justice Department set a record for merger challenges in fiscal year that ended Sept. 30, 2022. Last year, the FTC successfully blocked biotech company Illumina's over $7 billion acquisition of cancer-screening company Grail. The American Hospital Association has often criticized the Biden administration's antitrust enforcement approach.